Sanofi-Aventis to invest in R&D in Spain

Business Investments

01 Apr 2012

France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.

The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.

Source: IPA WORLD, 8/3/2012

Related news and success stories.


Subscribe to Catalonia in Business.

Do you want to be up to date with the latest news about Barcelona and Catalonia? Subscribe to our monthly newsletter and get them in your inbox.

Subscribe to Catalonia in Business
Contact with Catalonia Trade & Investment